1. Rising Prevalence of Influenza and Associated Chronic Diseases among Foremost Factors Driving the Market

The rise in the prevalence of Influenza and associated chronic diseases is one of the primary factors leading to growth and increase in the demand for the Influenza Diagnostics Market. The spectrum of influenza virus infection is wide, ranging from non-febrile to severe or even fatal complications, possessing high ongoing risks in seasonal and pandemic influenza.

This helps the multinational companies with a wide range of opportunities for the surveillance and monitoring of influenza activity of the pandemic one, at the global and national level, for individual patient management and guidance on the clinical management of influenza. Other factors, playing a vital role are associated chronic diseases, research funding for a better influenza diagnostics, rising demand for early diagnostics and control of influenza, and the emergence of technologically advanced influenza diagnostic tests, driving this Market.

2. Focus toward Rapid Influenza Diagnostic Tests (RIDTs) to hold High Market Share and Lead in Forecast Period

The scope of the study of this market includes segmentation by test type including traditional diagnostic tests and molecular diagnostic tests. In the traditional diagnostic tests, the RIDTs are expected to hold a high market share throughout the forecast period. The rapid tests are based on enzyme-linked immunosorbent assay (ELISA) with continuous improvement in the technical aspects of these tests making it more accurate, effective, and provide quick results. It is highly useful in to control interventions with timely implementation at the institutions, schools, and communities level. There is an increased level of commercial availability of RIDTs in developed markets and growing in demand in emerging countries with rising disposable income of public in these countries, thereby, helping to lead this segment.

Ask our Research Analyst to know more about the Market Dynamics and Market Segmentation

3. North America to hold Highest Share in this Market

North America is projected to hold the highest share in this market and lead the global market in terms of market share, particularly, due to increased involvement of the US Centers for Disease Control and Prevention (CDC) on controlling the diseases rates. It is further backed up by the increased healthcare expenditure each year, awareness among public for early diagnosis of diseases. With that, Asia-Pacific is expected to show fastest growth rate in forecast period due to multiple factors which provide high opportunities of growth for multinational companies.

4. Leading Companies to Watch

The report also examines the role of the leading market players involved in the industry. Some of the key players listed in the study are:

3M

Abbott

Becton, Dickinson and Company

DiaSorin s.p.a.

F. Hoffmann-La Roche AG

Luminex Corporation

Meridian Bioscience, Inc.

Quidel Corporation

Sekisui Diagnostics

Thermo Fisher Scientific Inc.

Access the Full Report to know more about each Key Players and their Competition

About Influenza Diagnostics Market

The Mordor Intelligence report values the global influenza diagnostic market to register a CAGR of nearly 8% over the forecast period of 2018-2023.

Get the full report from Mordor Intelligence to know more about Influenza Diagnostics Market

Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients worldwide

The post Vital Factors to Know about Influenza Diagnostics Market appeared first on Official Blog | Mordor Intelligence.